Immunai

Immunara

This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.

IMU

IMU Biosciences develops an immune profiling platform using machine learning to provide diagnostic insights for clinicians, researchers and pharmaceutical companies.

GraphTX

The company develops a platform for precision drug discovery by mapping live patient immune cell behaviour to identify therapeutic targets for inflammatory diseases.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.

One Biosciences

One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.

Enable Medicine

Enable Medicine provides a cloud-based spatial biology platform for life science researchers and pharmaceutical companies to analyse cellular data and discover new drug targets.

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.